Sunrise-D40000 IU

Sunrise-D 40000 IU is an essential fat-soluble vitamin that plays a critical role in calcium and phosphate metabolism, bone mineralization, and immune system regulation. It is indicated for the prevention and treatment of Vitamin D deficiency and related health conditions.

Primary Indications

• Vitamin D Deficiency
  Used in individuals with inadequate sunlight exposure or insufficient dietary intake of vitamin D, leading to fatigue, bone pain, and reduced mineral absorption.

Bone Health and Mineralization Disorders

• Prevention and management of rickets in children
  Supports proper bone formation and prevents skeletal deformities caused by poor mineralization.
• Prevention and treatment of osteomalacia in adults
  Helps improve bone strength and reduce bone pain due to softening of bones.
• Prevention of osteoporosis
  Enhances calcium absorption and bone density maintenance, reducing the risk of fractures in older adults.

Calcium and Phosphate Absorption Support

• Promotes efficient intestinal absorption of calcium and phosphate, which are essential for:
  • Strong bones and teeth
  • Normal skeletal growth and maintenance
  • Proper neuromuscular function

Pregnancy and Lactation Support

• Helps prevent complications such as pre-eclampsia during pregnancy
• Supports maternal Vitamin D requirements during pregnancy and breastfeeding
• Ensures adequate vitamin D supply for fetal and infant bone development

Immune System Support

• Plays an important role in immune modulation and defense mechanism enhancement
• Helps maintain overall immune balance and may reduce susceptibility to infections

Additional Supportive Roles (Expanded)

• Supports muscle function and strength, reducing risk of falls in elderly individuals
• Contributes to overall cardiovascular and metabolic health
• Helps maintain optimal serum calcium balance in long-term wellness

Summary

Sunrise-D 40000 IU is indicated for the prevention and treatment of Vitamin D deficiency and related bone disorders such as rickets, osteomalacia, and osteoporosis. It is also essential for calcium absorption, immune support, and maternal-fetal health during pregnancy and lactation, making it a vital nutrient for overall skeletal and systemic health.

Sunrise-D 40000 IU is a fat-soluble vitamin that undergoes sequential metabolic activation in the body to produce its biologically active form, which plays a central role in calcium-phosphate homeostasis, bone metabolism, and cellular regulation.

Absorption and Distribution

• Vitamin D3 is absorbed in the small intestine along with dietary fats.
• After absorption, it binds to specific α-globulin (vitamin D–binding protein) in the bloodstream.
• Being fat-soluble, it is distributed and stored in body tissues, particularly:
  • Adipose (fat) tissue
  • Muscle tissue
• It has a long biological half-life of approximately 50 days, allowing sustained physiological effects.

Metabolism (Activation Pathway)

Vitamin D3 undergoes two key hydroxylation steps for activation:

1. Liver Conversion:
   • Vitamin D3 is metabolized in the liver to 25-hydroxyvitamin D [25(OH)D] (Calcidiol)
   • This is the major circulating storage form and clinical marker of Vitamin D status
2. Kidney Activation:
   • Calcidiol is further hydroxylated in the kidneys to form 1,25-dihydroxyvitamin D [1,25(OH)₂D] (Calcitriol)
   • Calcitriol is the biologically active form responsible for most physiological effects

Mechanism of Action

• Calcitriol binds to Vitamin D Receptors (VDRs), which are widely distributed in various tissues, including:
  • Intestine
  • Bone
  • Kidney
  • Immune cells
• Activation of VDR leads to regulation of gene expression involved in:
  • Calcium and phosphate absorption
  • Bone mineralization and remodeling
  • Cellular differentiation and immune modulation

Physiological Effects

• Enhances intestinal absorption of calcium and phosphate
• Maintains serum calcium balance necessary for bone strength
• Supports bone formation, growth, and remodeling
• Contributes to muscle function and neuromuscular stability
• Plays a role in immune system regulation

Elimination

• Vitamin D3 and its metabolites are eliminated slowly through:
  • Feces
  • Urine
• Due to its fat solubility and tissue storage, clearance is gradual, contributing to its prolonged activity in the body.

Sunrise-D 40000 IU may interact with several medications that affect its metabolism, absorption, or physiological actions. These interactions may reduce its effectiveness or increase the risk of adverse effects such as altered calcium balance. Careful monitoring and dose adjustment may be required when used concomitantly with certain drugs.

Anticonvulsants (Phenytoin, Barbiturates)

• These drugs can increase hepatic metabolism of Vitamin D3, reducing its therapeutic effect.
• May lead to decreased serum Vitamin D levels and reduced calcium absorption.

Glucocorticoids

• Long-term corticosteroid therapy can reduce the effect of Vitamin D3 by:
  • Impairing calcium absorption
  • Increasing calcium excretion
• May contribute to bone loss and reduced Vitamin D activity.

Cardiac Glycosides (e.g., Digoxin)

• Concomitant use with Vitamin D3 (especially when combined with calcium) may:
  • Enhance the risk of arrhythmias due to increased serum calcium
• Requires:
  • Strict medical supervision
  • Regular ECG monitoring
  • Monitoring of serum calcium levels

Bile Acid Sequestrants (e.g., Cholestyramine)

• May reduce gastrointestinal absorption of Vitamin D3 by binding fat-soluble vitamins in the intestine.
• Can lead to reduced therapeutic efficacy.

Laxatives (e.g., Liquid Paraffin/Oil-based laxatives)

• May decrease absorption of fat-soluble vitamins, including Vitamin D3.
• Prolonged use may contribute to deficiency.

Antineoplastic and Antifungal Agents

• Actinomycin and imidazole antifungals may interfere with Vitamin D activation by:
  • Inhibiting renal enzyme 25-hydroxyvitamin D-1-hydroxylase
  • Reducing formation of active calcitriol (1,25-dihydroxyvitamin D)

Clinical Considerations

• Monitor serum calcium and Vitamin D levels in patients on long-term interacting medications
• Adjust Vitamin D dosage as required based on response
• Use caution in patients receiving multiple interacting drugs simultaneously

Sunrise-D 40000 IU is generally considered a safe and well-tolerated nutritional supplement when used at recommended doses. However, adverse effects may occur, particularly in cases of high-dose or prolonged use, individual sensitivity, or abnormal calcium metabolism.

General Safety Profile

• Vitamin D3 is usually well tolerated when taken within prescribed doses
• Most users do not experience significant adverse effects under normal supplementation

Metabolic and Calcium-Related Effects

• Hypercalcaemia (calcium intoxication)
  • May occur with excessive or prolonged dosing
  • Can lead to symptoms such as fatigue, weakness, or altered consciousness in severe cases
• Hypocalcaemia syndrome (rare and context-dependent)
  • May occur depending on underlying metabolic imbalance or treatment context

Gastrointestinal Symptoms

Occasionally reported, especially with higher doses:

• Nausea
• Vomiting
• Abdominal pain or stomach discomfort
• Constipation
• Loss of appetite (anorexia)

Neurological Symptoms

• Headache
• General weakness or fatigue (rare)

Dose-Related Risk

• Side effects are more likely with excessive or long-term high-dose use
• Toxicity is primarily related to elevated calcium levels (hypercalcaemia) rather than direct vitamin toxicity
• Risk increases when combined with additional calcium or Vitamin D supplements

Sunrise-D 40000 IU is an essential nutrient during pregnancy and breastfeeding, playing a key role in maternal bone health, fetal skeletal development, and calcium regulation. However, dosing should be carefully individualized based on clinical need and medical supervision.

Use During Pregnancy

• Clinical studies have shown that Vitamin D3 is safe in doses up to 4,000 IU daily during pregnancy.
• The recommended daily intake is approximately 400 IU, but requirements may vary depending on individual Vitamin D status.

Clinical Considerations:

• Higher doses may be required in pregnant women with Vitamin D Deficiency
• Supplementation should be individualized based on serum 25-hydroxyvitamin D levels
• Treatment decisions should always be guided by a healthcare professional to ensure optimal maternal and fetal outcomes

Use During Lactation (Breastfeeding)

• Vitamin D3 and its metabolites are excreted into breast milk
• However, vitamin D toxicity in breastfed infants has not been observed when mothers take recommended doses

Important Considerations:

• If a breastfed infant is receiving additional Vitamin D supplementation, clinicians should:
  • Evaluate the total Vitamin D intake from both mother and infant
  • Avoid excessive cumulative dosing
• Maternal supplementation is generally considered beneficial for maintaining adequate Vitamin D levels in both mother and infant

Clinical Guidance

• Dose requirements may vary based on:
  • Maternal Vitamin D status
  • Dietary intake and sunlight exposure
  • Presence of deficiency or high-risk conditions
• Regular monitoring may be recommended in high-risk pregnancies

The use of Sunrise-D 40000 IU requires careful medical supervision in certain patient groups due to its effects on calcium metabolism and potential risk of hypercalcaemia.

Monitoring Requirements

• Plasma calcium levels should be regularly monitored in:
  • Patients receiving high-dose Vitamin D3 therapy
  • Individuals with renal impairment
  • Pregnant and lactating women receiving supplementation

Regular monitoring helps prevent complications such as Hypercalcaemia.

Drug Interaction Precautions

Cardiac Glycosides (e.g., Digoxin)

• Patients using digoxin should consult a healthcare professional before taking Vitamin D3
• Increased calcium levels may enhance the risk of cardiac arrhythmias

Thiazide Diuretics

• Concomitant use may reduce urinary calcium excretion
• This can increase the risk of hypercalcaemia, requiring clinical monitoring

Medical Condition–Related Warnings

Patients with the following conditions should use Vitamin D3 only under strict medical supervision:

• Liver Disease
• Kidney Disease
• Hyperthyroidism
• Lymphoma
• Tuberculosis
• Granulomatous Disease

These conditions may increase sensitivity to Vitamin D3 or alter its metabolism, increasing the risk of toxicity.

Clinical Caution Points

• Avoid unsupervised high-dose supplementation
• Consider baseline and periodic monitoring of calcium and vitamin D status in high-risk individuals
• Use with caution in patients on multiple medications affecting calcium balance
• Adjust dosage based on clinical response and laboratory findings

Overdose of Sunrise-D 40000 IU may lead to serious metabolic disturbances, primarily due to excessive calcium accumulation in the blood and tissues.

Primary Toxic Effect

The most significant consequence of acute or chronic overdose is Hypercalcaemia, resulting from Vitamin D toxicity.

Acute Overdose Symptoms

Excessive intake of Vitamin D3 may cause the following symptoms:

• Nausea
• Vomiting
• Loss of appetite (anorexia)
• Weakness and fatigue
• Excessive thirst (polydipsia)
• Frequent urination (polyuria)
• Constipation
• Mental apathy or reduced alertness

These symptoms are mainly associated with elevated serum calcium levels.

Chronic Overdose Effects

Long-term excessive intake may result in more severe complications, including:

• Persistent hypercalcaemia
• Calcification of blood vessels (vascular calcification)
• Deposition of calcium in soft tissues and organs (e.g., kidneys, heart)
• Potential impairment of renal and cardiovascular function

Management of Overdose

In suspected Vitamin D toxicity, immediate medical intervention is required:

• Discontinue all sources of Vitamin D intake immediately
• Initiate adequate hydration (rehydration therapy)
• Monitor serum calcium and renal function
• Additional supportive treatment may be required depending on severity

Store in a cool (below 25°C) and dry place protected from light. Keep away from the reach of children.